GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 20, 2025, 4:00 PM EDT
GlobeStar Therapeutics Company Description
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, offers a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases.
The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021.
GlobeStar Therapeutics Corporation is based in New York, New York.
GlobeStar Therapeutics Corporation
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | James Katzaroff |
Contact Details
Address: 1280 Lexington Ave. New York, Wyoming 10028 United States | |
| Phone | 509-531-1671 |
| Website | globestartherapeutics.com |
Stock Details
| Ticker Symbol | GSTC |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | US37960P1049 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| James C. Katzaroff | President, Chief Executive Officer, Secretary, Principal Executive Officer and Chairman of the Board |
| Brooke Greenwald | Chief Marketing Officer |
| David Croom | Executive Vice President |